OQROGet OQRO Pro
Insider trade

Moderna (MRNA)President sold ~$8.28M

Stephen Hoge, President at Moderna, sold ~$8.28M of Moderna shares.

~$8.28M
Approx. value · 39K sh @ $213.47
1.6M
Holds after · shares reported
Traded
Oct 14, 2026
Filed
Oct 16, 2026

Context

Written by software from the filings listed below · Oct 18, 2026

  • What was filed. SEC Form 4 reports Stephen Hoge, President, Officer, sold 38,774 Moderna (MRNA) shares at $213.47 each, about $8.28M. The transaction date was Oct 14, 2026; it was filed on Oct 16, 2026, 2 days later.

4 more points, with the facts they come from, are in OQRO Pro.

Unlock OQRO Pro

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Aug 19, 2026Congress · 1 personMembers of Congress: 1 purchase, 1 sale
  2. Aug 27, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations (and 2 more items)
  3. Sep 1, 2026InsiderOfficer sold ~$486K of MRNA shares in the open market
  4. Sep 10, 2026Insider · 1 personInsiders: 2 sales (~$4.7M)
  5. Sep 14, 2026InsiderOfficer sold ~$5.81M of MRNA shares in the open market
  6. Sep 15, 2026InsiderOfficer sold ~$5.88M of MRNA shares in the open market
  7. Sep 24, 2026CongressDisclosed partial sale of MRNA — reported range $1,001 - $15,000
  8. Sep 30, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On September 30, 2026, Moderna, Inc. (“Moderna” or the “Company”) announced the appointment of Juan Andres as its Chief Operating Officer (“COO”) effective October 5, 2026.”
  9. Oct 14, 2026 · this disclosureInsiderOfficer sold ~$8.28M of MRNA shares in the open market

What came next

  1. Oct 14, 2026InsiderOfficer sold ~$96K of MRNA shares in the open market
  2. Oct 15, 2026InsiderOfficer sold ~$8.64M of MRNA shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Moderna

For Moderna, OQRO holds 17 insider filings (SEC Form 4 or Form 144), 3 Congress trade reports and 6 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MRNA page.

Other recent filings by Stephen Hoge, President

The full history of Stephen Hoge, President is on the profile page.

How this filing works

Explore the data

Other disclosures at Moderna

Everything OQRO holds on this company is on its MRNA page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data